Rafferty Asset Management’s Apellis Pharmaceuticals APLS Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$2.49M Sell
143,852
-36,282
-20% -$628K 0.01% 552
2025
Q1
$3.94M Sell
180,134
-61,340
-25% -$1.34M 0.02% 420
2024
Q4
$7.71M Buy
241,474
+37,328
+18% +$1.19M 0.03% 328
2024
Q3
$5.89M Sell
204,146
-37,836
-16% -$1.09M 0.02% 388
2024
Q2
$9.28M Buy
241,982
+93,181
+63% +$3.57M 0.03% 295
2024
Q1
$8.75M Buy
148,801
+5,683
+4% +$334K 0.03% 318
2023
Q4
$8.57M Sell
143,118
-71,043
-33% -$4.25M 0.04% 321
2023
Q3
$8.15M Buy
214,161
+121,893
+132% +$4.64M 0.05% 281
2023
Q2
$8.41M Sell
92,268
-17,130
-16% -$1.56M 0.05% 250
2023
Q1
$7.22M Sell
109,398
-54,706
-33% -$3.61M 0.05% 282
2022
Q4
$8.49M Buy
164,104
+61,532
+60% +$3.18M 0.07% 236
2022
Q3
$7.01M Buy
102,572
+9,683
+10% +$661K 0.07% 220
2022
Q2
$4.2M Sell
92,889
-30,606
-25% -$1.38M 0.04% 311
2022
Q1
$6.28M Sell
123,495
-2,415
-2% -$123K 0.04% 315
2021
Q4
$5.95M Buy
125,910
+36,711
+41% +$1.74M 0.03% 307
2021
Q3
$2.94M Buy
89,199
+47,208
+112% +$1.56M 0.02% 488
2021
Q2
$2.65M Sell
41,991
-29,421
-41% -$1.86M 0.02% 554
2021
Q1
$3.06M Buy
71,412
+52,653
+281% +$2.26M 0.02% 478
2020
Q4
$1.07M Sell
18,759
-50,470
-73% -$2.89M 0.01% 482
2020
Q3
$2.09M Buy
69,229
+38,410
+125% +$1.16M 0.03% 401
2020
Q2
$1.01M Buy
30,819
+22,557
+273% +$737K 0.01% 540
2020
Q1
$221K Sell
8,262
-61,996
-88% -$1.66M 0.01% 501
2019
Q4
$2.15M Buy
70,258
+10,579
+18% +$324K 0.03% 363
2019
Q3
$1.44M Sell
59,679
-5,124
-8% -$123K 0.02% 465
2019
Q2
$1.64M Buy
64,803
+37,450
+137% +$949K 0.03% 463
2019
Q1
$533K Buy
+27,353
New +$533K 0.01% 656